There were 813 press releases posted in the last 24 hours and 194,997 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

TO:
Ann Van Gysel
Turnstone Communications
+32 9 218 71 97

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image